Get the Stockscreener App
0.4174
28.71%
0.0977
Elite Pharmaceuticals, Inc. Stock (ELTP) Forecast
The Elite Pharmaceuticals, Inc. (ELTP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.0347, representing a -91.68% decrease from the current price of $0.4174. The highest analyst price target is $0.0338, and the lowest is $0.0357.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELTP Price Target
Average 0.0415
(-90.06% Downside)
Long-term ELTP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Elite Pharmaceuticals, Inc. financial reports and earnings history, Elite Pharmaceuticals, Inc. (ELTP) stock could reach $0.1438 by 2030, $0.434 by 2040 and $0.5354 by 2050. See the projected annual prices until 2050 of the Elite Pharmaceuticals, Inc. stock below:
- Elite Pharmaceuticals, Inc. (ELTP) is expected to reach an average price of $0.2723 in 2035, with a high prediction of $0.2831 and a low estimate of $0.275. This indicates an $-34.76% rise from the last recorded price of $0.4174.
- Elite Pharmaceuticals, Inc. (ELTP) stock is projected to chart a bullish course in 2040, with an average price target of $0.4186, representing an $0.30% surge from its current level. The forecast ranges from a conservative $0.422 to a sky-high $0.434.
- Our analysts predict Elite Pharmaceuticals, Inc. (ELTP) to jump 35.77% by 2045, soaring from $0.409 to an average price of $0.5667, potentially reaching $0.5798. While $0.409 is the low estimate, the potential upside is significant.
- Elite Pharmaceuticals, Inc. (ELTP) stock is expected to climb by 2050, reaching an average of $0.5223, a $25.13% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.5354 and $0.5091, respectively, highlighting the market's uncertainty.
Elite Pharmaceuticals, Inc. Stock (ELTP) Year by Year Forecast
Elite Pharmaceuticals, Inc. Stock (ELTP) Price Forecast for 2025
Elite Pharmaceuticals, Inc. Stock (ELTP) is expected to reach an average price of $0.031 in 2025, with a high prediction of $0.0456 and a low estimate of $0.0163. This indicates an -92.58% fall from the last recorded price of $0.4174.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.0328 | $0.0357 | $0.0338 | -92.13% |
| June, 2025 | $0.0341 | $0.0339 | $0.0315 | -91.83% |
| July, 2025 | $0.0258 | $0.0308 | $0.0311 | -93.82% |
| August, 2025 | $0.0246 | $0.0265 | $0.0243 | -94.11% |
| September, 2025 | $0.0439 | $0.0256 | $0.0443 | -89.48% |
| October, 2025 | $0.048 | $0.0474 | $0.0425 | -88.51% |
| November, 2025 | $0.0443 | $0.0454 | $0.0456 | -89.38% |
| December, 2025 | $0.0407 | $0.0447 | $0.0427 | -90.24% |
Elite Pharmaceuticals, Inc. Stock (ELTP) Price Forecast for 2026
The predicted value for Elite Pharmaceuticals, Inc. (ELTP) in 2026 is set at an average of $0.0523. Estimates vary from a peak of $0.0698 to a trough of $0.0348, indicating an -87.47% surge from the present price of $0.4174.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0318 | $0.039 | $0.0368 | -92.38% |
| February, 2026 | $0.033 | $0.0348 | $0.032 | -92.08% |
| March, 2026 | $0.0569 | $0.0356 | $0.057 | -86.37% |
| April, 2026 | $0.0561 | $0.0599 | $0.0574 | -86.55% |
| May, 2026 | $0.0541 | $0.0568 | $0.0538 | -87.05% |
| June, 2026 | $0.0462 | $0.0512 | $0.0525 | -88.93% |
| July, 2026 | $0.0437 | $0.0456 | $0.0445 | -89.52% |
| August, 2026 | $0.0691 | $0.0441 | $0.0698 | -83.45% |
| September, 2026 | $0.0719 | $0.072 | $0.0674 | -82.78% |
| October, 2026 | $0.067 | $0.0683 | $0.0692 | -83.95% |
| November, 2026 | $0.0618 | $0.0658 | $0.065 | -85.20% |
| December, 2026 | $0.0516 | $0.0591 | $0.0576 | -87.64% |
Elite Pharmaceuticals, Inc. Stock (ELTP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Elite Pharmaceuticals, Inc. (ELTP) is $0.0743, with a high forecast of $0.0953 and a low forecast of $0.0534. This indicates an -82.20% decrease from the last price of $0.4174.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0516 | $0.0534 | $0.0506 | -87.64% |
| February, 2027 | $0.0818 | $0.0539 | $0.0825 | -80.40% |
| March, 2027 | $0.0794 | $0.0839 | $0.081 | -80.98% |
| April, 2027 | $0.0761 | $0.0788 | $0.0762 | -81.77% |
| May, 2027 | $0.0666 | $0.0716 | $0.074 | -84.03% |
| June, 2027 | $0.0629 | $0.0648 | $0.0646 | -84.93% |
| July, 2027 | $0.0975 | $0.0626 | $0.0953 | -76.64% |
| August, 2027 | $0.0958 | $0.0963 | $0.094 | -77.05% |
| September, 2027 | $0.0896 | $0.0913 | $0.0928 | -78.52% |
| October, 2027 | $0.0855 | $0.0886 | $0.0873 | -79.52% |
| November, 2027 | $0.0714 | $0.0789 | $0.0828 | -82.90% |
| December, 2027 | $0.0701 | $0.0719 | $0.0691 | -83.20% |
Elite Pharmaceuticals, Inc. Stock (ELTP) Price Forecast for 2028
In 2028, Elite Pharmaceuticals, Inc. (ELTP) is projected to reach an average price of $0.1028, with a high projection of $0.1335 and a low estimate of $0.0721. This indicates an -75.38% fall from the last price of $0.4174.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.106 | $0.0721 | $0.108 | -74.61% |
| February, 2028 | $0.1027 | $0.1072 | $0.1046 | -75.40% |
| March, 2028 | $0.0981 | $0.1008 | $0.0985 | -76.50% |
| April, 2028 | $0.0887 | $0.0947 | $0.0957 | -78.75% |
| May, 2028 | $0.0821 | $0.084 | $0.0866 | -80.34% |
| June, 2028 | $0.123 | $0.0812 | $0.1208 | -70.53% |
| July, 2028 | $0.1197 | $0.1205 | $0.1192 | -71.32% |
| August, 2028 | $0.1123 | $0.1143 | $0.1164 | -73.10% |
| September, 2028 | $0.1069 | $0.11 | $0.1097 | -74.40% |
| October, 2028 | $0.0912 | $0.0987 | $0.1039 | -78.16% |
| November, 2028 | $0.0886 | $0.0904 | $0.0876 | -78.76% |
| December, 2028 | $0.1316 | $0.0903 | $0.1335 | -68.48% |
Elite Pharmaceuticals, Inc. Stock (ELTP) Price Forecast for 2029
The 2029 price forecast for Elite Pharmaceuticals, Inc. Stock (ELTP) is $0.1292 on average, with a high prediction of $0.159 and a low estimate of $0.0994. This represents an -69.05% decrease from the previous price of $0.4174.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.126 | $0.1305 | $0.1282 | -69.82% |
| February, 2029 | $0.1201 | $0.1228 | $0.1209 | -71.23% |
| March, 2029 | $0.1094 | $0.1154 | $0.1174 | -73.78% |
| April, 2029 | $0.1012 | $0.1031 | $0.107 | -75.75% |
| May, 2029 | $0.1485 | $0.0994 | $0.1463 | -64.42% |
| June, 2029 | $0.1417 | $0.1447 | $0.1444 | -66.04% |
| July, 2029 | $0.1349 | $0.1372 | $0.14 | -67.67% |
| August, 2029 | $0.1283 | $0.1314 | $0.132 | -69.27% |
| September, 2029 | $0.1158 | $0.1195 | $0.125 | -72.25% |
| October, 2029 | $0.1072 | $0.109 | $0.1104 | -74.33% |
| November, 2029 | $0.1564 | $0.1085 | $0.159 | -62.52% |
| December, 2029 | $0.1493 | $0.1538 | $0.1518 | -64.24% |
Elite Pharmaceuticals, Inc. Stock (ELTP) Price Forecast for 2030
Elite Pharmaceuticals, Inc. Stock (ELTP) is expected to reach an average price of $0.151 in 2030, with a high forecast of $0.1845 and a low forecast of $0.1176. This signifies an -63.81% decrease from the last price of $0.4174.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.1421 | $0.1448 | $0.1438 | -65.95% |
| February, 2030 | $0.1302 | $0.1362 | $0.1391 | -68.81% |
| March, 2030 | $0.1193 | $0.1258 | $0.1274 | -71.41% |
| April, 2030 | $0.174 | $0.1176 | $0.1718 | -58.31% |
| May, 2030 | $0.166 | $0.169 | $0.1696 | -60.24% |
| June, 2030 | $0.1575 | $0.1602 | $0.1636 | -62.27% |
| July, 2030 | $0.1496 | $0.1528 | $0.1547 | -64.15% |
| August, 2030 | $0.136 | $0.1396 | $0.146 | -67.43% |
| September, 2030 | $0.1257 | $0.1275 | $0.1302 | -69.89% |
| October, 2030 | $0.1813 | $0.1267 | $0.1845 | -56.57% |
| November, 2030 | $0.1767 | $0.18 | $0.1754 | -57.66% |
| December, 2030 | $0.1641 | $0.1668 | $0.1715 | -60.68% |
1.88%
2.04%
Cap:
|
Volume (24h):